Patients with generalized pustular psoriasis experienced flares despite the use of traditional off-label therapies and frequently changed treatment.

Boehringer Ingelheim announced new analyses to be presented at the American Academy of Dermatology (AAD) annual meeting in Orlando that explore the effect that SPEVIGO® (spesolimab-sbzo) may have on ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

Generalized pustular psoriasis (GPP) can range in severity and may be life threatening for some people. Treatment typically includes a variety of topical, oral, and injectable medications.

Vanda projects 2025 revenues between $210 million and $250 million, representing growth of 6% to 26% compared to 2024. This forecast includes Fanapt, HETLIOZ, and PONVORY but excludes potential ...

Generalized Pustular Psoriasis Market Outlook 2025-2035: The 7 major generalized pustular psoriasis market reached a value of USD 19.6 Billion in 2024. Looking forward, IMARC Group expects the 7MM to ...

You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...

The abnormal turnover and dynamics of mitochondria in skeletal muscles are associated with disease progression in spinal muscular atrophy (SMA) in a mouse model of the disease, according to a new ...

The rapid onset and resolution of the pustular eruption upon discontinuation of isotretinoin further supported the diagnosis of AGEP. Isotretinoin has the potential to trigger acute generalized ...

16 When evaluating a patient who may have GPP, it is important to consider and rule out other cutaneous pustular diagnoses, such as acute generalized exanthematous pustulosis (AGEP). AGEP is ...